Tahir Ali | PRION 2025 | Galoá Proceedings

Ottawa University

Tahir Ali

Is this your profile? Do login to access your certificates

Treatment with anti-retroviral drug Efavirenz activates cholesterol hydroxylation and extends survival in Creutzfeldt-Jakob disease model
Gilch, Sabine ¹
Ali, Tahir ²
Cashion, Jessica ¹
HANNAOUI, SAMIA ¹
Ahmed-Hassan, Hanaa ³
Schätzl, Hermann ⁴
¹ University of Calgary
² Ottawa University
³ Calgary Prion Research Unit, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
⁴ Calgary Prion Research Unit, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Calgary Prion Research Unit, Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
Vol 1, 2025 -
328790

Therapeutic approaches for prion and prion-like diseases

Abstract Prion 2025

Co-authors (5)